Literature DB >> 731412

Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.

K C Kwan, G O Breault, R L Davis, B W Lei, A W Czerwinski, G H Besselaar, D E Duggan.   

Abstract

Ten healthy volunteers each received single and multiple 50-mg doses of indomethacin orally and a single 25-mg dose of [14C]indomethacin intravenously in the absence of and concomitantly with 1200 mg of aspirin as a single dose and in a chronic t.i.d. regimen. Systematic analysis of the data resulted in the isolation and quantification of aspirin's effects on the absorption, distribution, biotransformation, excretion, enterohepatic circulation, and accumulation of indomethacin. The effects of chronic aspirin were to suppress the renal clearance, to increase the biliary clearance, to decrease the efficiency of gastrointestinal absorption, and to enhance the enterohepatic circulation of indomethacin. On concomitant administration of 1200 mg of aspirin t.i.d., mean plasma levels of indomethacin were depressed by 20% after a single oral dose, by a smaller margin after multiple oral doses, and not at all after a single intravenous dose of indomethacin. The mean plasma concentration of orally administered indomethacin was decreased by 8% when given concurrently with a single 1200 mg dose of aspirin. Concomitant chronic therapeutic dosages of indomethacin had no effect on salicylate accumulation from repetitive doses of aspirin.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 731412     DOI: 10.1007/bf01062103

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  22 in total

1.  The effect of salicylate on the passage of a barium meal in the rat.

Authors:  M J SMITH; J D IRVING
Journal:  Br J Radiol       Date:  1955-01       Impact factor: 3.039

2.  The effect of buffered aspirin on plasma indomethacin.

Authors:  J C Garnham; K Raymond; E Shotton; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1975-02-28       Impact factor: 2.953

3.  Interactions of aspirin with nonsteroidal antiinflammatory drugs in man.

Authors:  A Rubin; B E Rodda; P Warrick; C M Gruber; A S Ridolfo
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

4.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

5.  An integrated approach to the pharmacokinetic analysis of drug absorption.

Authors:  A E Till; L Z Benet; K C Kwan
Journal:  J Pharmacokinet Biopharm       Date:  1974-12

6.  A simplified method for measurement of albumin turnover using 131 I-labelled human albumin.

Authors:  H Oberli; H Koblet
Journal:  Helv Med Acta       Date:  1973

7.  Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

Authors:  M Rowland; S Riegelman; P A Harris; S D Sholkoff
Journal:  J Pharm Sci       Date:  1972-03       Impact factor: 3.534

8.  The renal excretion of indomethacin and its inhibition by probenecid.

Authors:  M D Skeith; P A Simkin; L A Healey
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

9.  Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats.

Authors:  D W Yesair; L Remington; M Callahan; C J Kensler
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

10.  Enterohepatic circulation of indomethacin and its role in intestinal irritation.

Authors:  D E Duggan; K F Hooke; R M Noll; K C Kwan
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

View more
  10 in total

1.  Influence of chronic diflunisal treatment on the plasma levels, metabolism and excretion of indomethacin.

Authors:  L O Eriksson; E Wåhlin-Boll; H Liedholm; P Seideman; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

Review 3.  Drug interactions involving aspirin (acetylsalicylic acid) and salicylic acid.

Authors:  J O Miners
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

4.  Estimation of area under the curve for drugs subject to enterohepatic cycling.

Authors:  T A Shepard; R H Reuning; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

5.  Interaction between flurbiprofen and indomethacin in rheumatoid arthritis.

Authors:  S R Rudge; J K Lloyd-Jones; I D Hind
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

Review 6.  Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.

Authors:  C Durnas; B J Cusack
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

7.  Clinical Pharmacokinetics of indomethacin.

Authors:  L Helleberg
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 8.  Adverse drug interactions with nonsteroidal anti-inflammatory drugs (NSAIDs). Recognition, management and avoidance.

Authors:  A G Johnson; P Seideman; R O Day
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

9.  Biliary elimination of indomethacin in man.

Authors:  B Terhaag; U Hermann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 10.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.